| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 11,399,859 | 12,904,360 | 10,880,483 | | Cost of Revenue | 8,450,889 | 8,837,630 | 7,631,102 | | | Gross Profit | 2,948,970 | 4,066,730 | 3,249,381 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,510,394 | 2,542,530 | 2,104,449 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 438,576 | 1,524,200 | 1,144,932 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 73,828 | 178,110 | 173,424 | | Earnings Before Interest And Taxes | 577,657 | 1,763,220 | 1,340,568 | | Interest Expense | 12,182 | 14,800 | 13,958 | | Income Before Tax | 565,475 | 1,748,420 | 1,326,610 | | Income Tax Expense | 230,091 | 602,350 | 414,297 | | Minority Interest | (37,344) | (73,630) | (53,593) | | | | Net Income From Continuing Ops | 298,040 | 1,072,440 | 858,720 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 43,856 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 298,040 | 1,072,440 | 902,576 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $298,040 | $1,072,440 | $902,576 |
|
0.36% Nasdaq 
Income Statement
